Application	O
of	O
clonal	O
analysis	O
.	O

Differential	O
diagnosis	O
for	O
synchronous	O
primary	B-Cancer
ovarian	I-Cancer
and	O
endometrial	B-Cancer
cancers	I-Cancer
and	O
metastatic	B-Cancer
cancer	I-Cancer
.	O

Simultaneous	O
involvement	O
of	O
the	O
endometrium	B-Multi-tissue_structure
and	O
the	O
ovary	B-Organ
by	O
carcinoma	B-Cancer
is	O
a	O
familiar	O
problem	O
in	O
the	O
routine	O
practice	O
of	O
surgical	O
pathology	O
.	O

Such	O
cases	O
may	O
be	O
considered	O
either	O
examples	O
of	O
a	O
single	O
primary	B-Cancer
carcinoma	I-Cancer
with	O
metastasis	O
or	O
as	O
synchronous	B-Cancer
primary	I-Cancer
neoplasms	I-Cancer
.	O

The	O
distinction	O
between	O
these	O
two	O
possibilities	O
is	O
made	O
based	O
on	O
clinicopathologic	O
observations	O
,	O
and	O
therefore	O
may	O
not	O
be	O
definitive	O
.	O

In	O
the	O
present	O
study	O
,	O
the	O
authors	O
used	O
molecular	O
techniques	O
to	O
analyze	O
the	O
clonal	O
composition	O
of	O
five	O
cases	O
of	O
concurrent	O
adenocarcinomas	B-Cancer
of	O
the	O
endometrium	B-Multi-tissue_structure
and	O
ovary	B-Organ
that	O
were	O
clinicopathologically	O
diagnosed	O
as	O
synchronous	B-Cancer
primary	I-Cancer
tumors	I-Cancer
.	O

Patterns	O
of	O
X	B-Cellular_component
-	I-Cellular_component
chromosome	I-Cellular_component
inactivation	O
,	O
mutations	O
in	O
the	O
K	O
-	O
ras	O
gene	O
,	O
mutations	O
or	O
allelic	O
loss	O
of	O
the	O
p53	O
gene	O
,	O
or	O
human	O
papillomavirus	O
detection	O
were	O
identical	O
in	O
both	O
endometrial	B-Pathological_formation
and	O
ovarian	B-Pathological_formation
lesions	I-Pathological_formation
in	O
three	O
of	O
the	O
cases	O
suggesting	O
that	O
those	O
three	O
cases	O
represented	O
single	O
primary	B-Cancer
tumors	I-Cancer
with	O
metastases	B-Cancer
.	O

In	O
both	O
of	O
the	O
other	O
two	O
cases	O
,	O
the	O
patterns	O
of	O
X	B-Cellular_component
-	I-Cellular_component
chromosome	I-Cellular_component
inactivation	O
clearly	O
demonstrated	O
the	O
presence	O
of	O
independent	O
primary	B-Cancer
tumors	I-Cancer
.	O

The	O
application	O
of	O
molecular	O
technology	O
may	O
play	O
an	O
important	O
role	O
for	O
the	O
differential	O
diagnosis	O
between	O
synchronous	B-Cancer
primary	I-Cancer
carcinomas	I-Cancer
and	O
a	O
single	O
carcinoma	B-Cancer
with	O
metastasis	B-Cancer
.	O

